NCT00758303View on ClinicalTrials.gov

A Study to Evaluate the Lipid Regulating Effects of TRIA-662

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

211

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Hyperlipidemia
Interventions
DRUG

Low Dose TRIA-662

One Capsule 3 times a day

DRUG

High Dose TRIA-662

3 Capsules 3 times daily

DRUG

Placebo for TRIA-662

Matching Placebo for TRIA-662 taken 3 times a day

Sponsors
All Listed Sponsors
lead

Cortria Corporation

INDUSTRY